Melissa A. Lerman

Pediatric Rheumatology

3500 Civic Center Blvd
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Rapidly Progressive Idiopathic Pyoderma Gangrenosum in a Pediatric Patient Successfully Treated With Infliximab.

Rapidly Progressive Idiopathic Pyoderma Gangrenosum in a Pediatric Patient Successfully Treated With Infliximab.

Journal: Pediatric dermatology

Published: July 26, 2024

A randomized controlled educational study to evaluate an e-learning module to teach the physical examination of the temporomandibular joint in juvenile idiopathic arthritis.

A randomized controlled educational study to evaluate an e-learning module to teach the physical examination of the temporomandibular joint in juvenile idiopathic arthritis.

Journal: Pediatric rheumatology online journal

Published: June 03, 2024

Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research.

Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research.

Journal: Pediatric rheumatology online journal

Published: May 03, 2024

Uveitis treatment in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: response to tumour necrosis factor inhibitors.

Uveitis treatment in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: response to tumour necrosis factor inhibitors.

Journal: Clinical and experimental rheumatology

Published: April 10, 2024

Measurable Outcomes of an Ophthalmology and Rheumatology Coordinated Care Clinic.

Measurable Outcomes of an Ophthalmology and Rheumatology Coordinated Care Clinic.

Journal: Arthritis care & research

Published: February 08, 2024

Provider assessment of the temporomandibular joint in Juvenile idiopathic arthritis: a retrospective analysis from the CARRA database.

Provider assessment of the temporomandibular joint in Juvenile idiopathic arthritis: a retrospective analysis from the CARRA database.

Journal: Pediatric rheumatology online journal

Published: January 09, 2024

Avoid a rash diagnosis: reconsidering cytophagic histiocytic panniculitis as a distinct clinical-pathologic entity.

Avoid a rash diagnosis: reconsidering cytophagic histiocytic panniculitis as a distinct clinical-pathologic entity.

Journal: JAAD case reports

Published: May 22, 2023

Opening Wide: Advances in Understanding Temporomandibular Joint Involvement in Juvenile Idiopathic Arthritis.

Opening Wide: Advances in Understanding Temporomandibular Joint Involvement in Juvenile Idiopathic Arthritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 15, 2023

Improving Outcomes of Pediatric Lupus Care Delivery With Provider Goal-Setting Activities and Multidisciplinary Care Models.

Improving Outcomes of Pediatric Lupus Care Delivery With Provider Goal-Setting Activities and Multidisciplinary Care Models.

Journal: Arthritis care & research

Published: December 16, 2022

Management of Orofacial Manifestations of Juvenile Idiopathic Arthritis: Interdisciplinary Consensus-Based Recommendations.

Management of Orofacial Manifestations of Juvenile Idiopathic Arthritis: Interdisciplinary Consensus-Based Recommendations.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: December 21, 2021

The Temporomandibular Joint in Juvenile Idiopathic Arthritis.

The Temporomandibular Joint in Juvenile Idiopathic Arthritis.

Journal: Rheumatic diseases clinics of North America

Published: October 12, 2021

Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.

Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.

Journal: Lancet (London, England)

Published: March 01, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026